https://www.selleckchem.com/pr....oducts/3-deazaadenos
5% vs. 4.8%, p less then .05) or being excluded from study enrollment (43.6% vs. 0%, p less then 0.01). Comparing the first and second pilot RCTs, regardless of study arm, families in the second pilot were more likely to complete diagnostic assessment (UC HR 3.41, 95% CI [1.20, 9.68]; FN HR 2.64, 95% CI [1.31, 5.30]) and report greater satisfaction with clinical care. In the second pilot, compared to UC, FN continued increase the likelihood of completing the diagnostic assessment (HR 2.57; 95% CI [1.22, 5.40]). CO
Like
Comment
Share
